Controlling brain circuits with light

May 3, 2011 in Medical research

F1000 Biology Reports, the open-access, peer-reviewed journal from Faculty of 1000, today published a historical account of the beginnings of the optogenetic revolution by Edward Boyden.

Commenting on Edward Boyden's article, Ben Barres, Head of the Neuronal & Glial Cell Biology Section of Faculty of 1000 and Professor at Stanford University School of Medicine said: "There will probably be a Nobel prize for optogenetics someday as it has revolutionized our attempts to understand how the works. This article provides a fascinating insight into the birth of optogenetics and the roles of the major players."

The invention of optogenetics literally sheds light on how our brains work. Published in the May 2011 issue of F1000 Biology Reports, Edward Boyden's revealing article gives a unique perspective on the birth of optogenetics tools, new resources for analyzing and engineering brain circuits. These 'tools' take the form of genetically encoded molecules that, when targeted to specific neurons in the brain, enable their activity to be driven or silenced by light, thus revealing how entire neural circuits operate.

By driving or quieting the activity of defined neurons embedded with an intact neural network, Boyden and his colleagues are able to determine what behaviors, neural computations, or pathologies those neurons were sufficient to cause or what brain functions, or pathologies, these neurons are necessary for.

These tools are also being explored as components of neural control prosthetics capable of correcting neural circuit computations that have gone awry in brain disorders. Part of a systematic approach to neuroscience that is empowering new therapeutic strategies for neurological and psychiatric disorders, optogenetic tools are widely accepted as one of the technical advances of the decade, and could one day be used to treat neurological disorders such as Parkinsons.

Using primary sources and his own experiences at Stanford, Boyden reconstructs a compelling case study of the development of optogenetic tools, providing an insight into the hard work and serendipity involved.

Provided by Faculty of 1000: Biology and Medicine

3 /5 (1 vote)  

Rank 3 /5 (1 vote)
Tags

Relevant PhysicsForums posts

More news stories

Study reveals new mechanism for estrogen suppression of liver lipid synthesis

By discovering the new mechanism by which estrogen suppresses lipid synthesis in the liver, UC Irvine endocrinologists have revealed a potential new approach toward treating certain liver diseases.

Medical research created May 23, 2013 | popularity 5 / 5 (1) | comments 0 | with audio podcast

MRI-based measurement helps predict vascular disease in the brain

Aortic arch pulse wave velocity, a measure of arterial stiffness, is a strong independent predictor of disease of the vessels that supply blood to the brain, according to a new study published in the June issue the journal ...

Medical research created May 23, 2013 | popularity not rated yet | comments 0

Antibiotics: A new understanding of sulfonamide nervous system side effects

Since the discovery of Prontosil in 1932, sulfonamide antibiotics have been used to combat a wide spectrum of bacterial infections, from acne to chlamydia and pneumonia. However, their side effects can include serious neurological ...

Medical research created May 23, 2013 | popularity 3 / 5 (1) | comments 0 | with audio podcast

Scientists discover molecule triggers sensation of itch

Scientists at the National Institutes of Health report they have discovered in mouse studies that a small molecule released in the spinal cord triggers a process that is later experienced in the brain as ...

Medical research created May 23, 2013 | popularity 5 / 5 (3) | comments 0 | with audio podcast

Discarded immune cells induce the relocation of stem cells

Spanish researchers have discovered that the daily clearance of neutrophils from the body stimulates the release of hematopoietic stem cells from the bone marrow into the bloodstream, according to a report published today ...

Medical research created May 23, 2013 | popularity 5 / 5 (2) | comments 0


First drug to improve heart failure mortality in over a decade

Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...

Seniors more likely to crash when driving with pet, study finds

(HealthDay)—Animals make great companions for senior citizens, but elderly people who always drive with a pet in the car are far more likely to crash than those who never drive with a pet, researchers have ...

Heart failure accelerates male 'menopause'

Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...

Death highest in heart failure patients admitted in January, on Friday, and overnight

Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...

Feds fight morning-after pill age ruling in NY

(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...

New immune system discovered

(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.